DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2193148/centene-cnc-wins-contract-from-arizona-s-medicaid-agency?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2193148 Dec 04, 2023 - Centene's (CNC) Arizona subsidiary has been chosen by the AHCCCS to improve health outcomes for the state's ALTCS-E/PD members and further solidify statewide presence. 0

https://www.zacks.com/stock/news/2193656/why-you-should-retain-unitedhealth-group-unh-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2193656 Dec 05, 2023 - Growing membership, expanding government business, strategic acquisitions, improving operating margin and solid growth outlook poise UnitedHealth Group (UNH) well for growth. 0

https://www.zacks.com/stock/news/2196609/what-s-in-store-for-nasdaq-in-2024-5-top-picks?cid=CS-ZC-FT-analyst_blog|investment_ideas-2196609 Dec 12, 2023 - After a strong 2023, we expect the Nasdaq to log gains in 2024. Top-ranked Nasdaq stocks GigaCloud Technology Inc (GCT), Carrols Restaurant Group (TAST), Limbach (LMB), Amphastar Pharmaceuticals (AMPH) and Insight Enterprises Inc (NSIT) could emerge as winning picks. 0

https://www.zacks.com/stock/news/2202621/wall-street-analysts-think-amphastar-amph-is-a-good-investment-is-it?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2202621 Dec 27, 2023 - According to the average brokerage recommendation (ABR), one should invest in Amphastar (AMPH). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock? 0

https://www.zacks.com/stock/news/2203857/here-s-why-you-should-retain-centene-cnc-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2203857 Dec 29, 2023 - Centene (CNC) remains well-poised for growth on the back of overall membership growth, acquisitions, business streamlining efforts and a growing cash balance. 0

https://www.zacks.com/stock/news/2209962/snap-these-4-top-ranked-liquid-stocks-to-drive-solid-returns?cid=CS-ZC-FT-analyst_blog|rw-2209962 Jan 15, 2024 - Here are four top-performing liquid stocks, American Public Education (APEI), Amphastar Pharmaceuticals (AMPH), GigaCloud (GCT) and Oceaneering International (OII), which investors can add to their portfolio to boost returns. 0

https://www.zacks.com/stock/news/2193736/are-you-looking-for-a-top-momentum-pick-why-amphastar-pharmaceuticals-amph-is-a-great-choice?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2193736 Dec 05, 2023 - Does Amphastar Pharmaceuticals (AMPH) have what it takes to be a top stock pick for momentum investors? Let's find out. 0

https://www.zacks.com/stock/news/2202102/5-good-opportunities-on-relative-price-strength-strategy?cid=CS-ZC-FT-analyst_blog|rw-2202102 Dec 26, 2023 - AMPH, FOUR, BECN, HOFT and HTH are five stocks with explosive relative price strength. 0

https://www.zacks.com/stock/news/2202634/are-medical-stocks-lagging-arch-therapeutics-arth-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-2202634 Dec 27, 2023 - Here is how Arch Therapeutics, Inc. (ARTH) and Amphastar Pharmaceuticals (AMPH) have performed compared to their sector so far this year. 0

https://www.zacks.com/stock/news/2204183/amphastar-pharmaceuticals-amph-is-up-1-53-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2204183 Jan 01, 2024 - Does Amphastar Pharmaceuticals (AMPH) have what it takes to be a top stock pick for momentum investors? Let's find out. 0